Mori Hamada provided legal advice to Chugai Pharmaceutical Co., Ltd. in connection with its acquisition of Renalys Pharma, Inc., a Japan-based biotechnology venture company, making it a wholly-owned subsidiary.
The Mori Hamada team was led by Yo Uraoka, Daiki Ishikawa, Masaki Kakimoto, Kana Nando, Yu Hayami, Yuta Kawasaki.
For details on this matter, please refer to the press release and other disclosure documents.
Period
October 2025
Practices
People
Related Cases
My Page
Mori Hamada My Page
(Members' Portal)
The firm's “Mori Hamada My Page” service enables gathering and viewing of information on seminars, newsletters, publications, public announcements from government agencies, and other matters all in one centralized portal.
